Hemas Holdings Plc

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: LK0337N00002
LKR
33.70
-0.1 (-0.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 6.95

 
2

Low Debt Company with Strong Long Term Fundamental Strength

 
3

Flat results in Dec 25

4

With ROE of 17.59%, it has a attractive valuation with a 2.18 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

LKR 101,483 Million (Large Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.00

stock-summary
Return on Equity

16.59%

stock-summary
Price to Book

1.91

Revenue and Profits:
Net Sales:
35,009 Million
(Quarterly Results - Dec 2025)
Net Profit:
2,744 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.07%
0%
-5.07%
6 Months
9.06%
0%
9.06%
1 Year
38.11%
0%
38.11%
2 Years
128.94%
0%
128.94%
3 Years
-47.34%
0%
-47.34%
4 Years
164.11%
0%
164.11%
5 Years
109.58%
0%
109.58%

Hemas Holdings Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.00%
EBIT Growth (5y)
20.53%
EBIT to Interest (avg)
6.95
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
2.05
Tax Ratio
35.76%
Dividend Payout Ratio
33.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.07%
ROE (avg)
14.05%

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.18
EV to EBIT
8.23
EV to EBITDA
7.03
EV to Capital Employed
2.31
EV to Sales
0.84
PEG Ratio
NA
Dividend Yield
0.06%
ROCE (Latest)
28.02%
ROE (Latest)
17.59%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 8.43% vs 13.18% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 27.01% vs 72.10% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35,009.00",
          "val2": "32,286.90",
          "chgp": "8.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,615.30",
          "val2": "3,957.70",
          "chgp": "16.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "235.20",
          "val2": "186.20",
          "chgp": "26.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,743.90",
          "val2": "2,160.40",
          "chgp": "27.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "115.00%",
          "val2": "104.80%",
          "chgp": "1.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -3.00% vs 6.74% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 31.22% vs 25.37% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "117,970.20",
          "val2": "121,613.80",
          "chgp": "-3.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14,160.30",
          "val2": "12,756.40",
          "chgp": "11.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,500.40",
          "val2": "3,254.60",
          "chgp": "-53.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "336.20",
          "val2": "265.00",
          "chgp": "26.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,338.70",
          "val2": "6,354.70",
          "chgp": "31.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "103.10%",
          "val2": "91.10%",
          "chgp": "1.20%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
35,009.00
32,286.90
8.43%
Operating Profit (PBDIT) excl Other Income
4,615.30
3,957.70
16.62%
Interest
235.20
186.20
26.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,743.90
2,160.40
27.01%
Operating Profit Margin (Excl OI)
115.00%
104.80%
1.02%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 8.43% vs 13.18% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 27.01% vs 72.10% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
117,970.20
121,613.80
-3.00%
Operating Profit (PBDIT) excl Other Income
14,160.30
12,756.40
11.01%
Interest
1,500.40
3,254.60
-53.90%
Exceptional Items
336.20
265.00
26.87%
Consolidate Net Profit
8,338.70
6,354.70
31.22%
Operating Profit Margin (Excl OI)
103.10%
91.10%
1.20%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -3.00% vs 6.74% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 31.22% vs 25.37% in Mar 2024

stock-summaryCompany CV
About Hemas Holdings Plc stock-summary
stock-summary
Hemas Holdings Plc
Pharmaceuticals & Biotechnology
Hemas Holdings PLC (Hemas) is a Sri Lanka-based pharmaceuticals company engaged in healthcare, leisure and transportation services. The Company operates in various segments, such as FMCG, Healthcare, Leisure, Transportation, Power and others. The FMCG business sector manufactures and markets personal care and home care branded products. Its Healthcare sector is a distributor of pharmaceuticals, surgical and diagnostic products in Sri Lanka. Its Leisure sector consists of the Serendib Leisure Group of Hotels. The Transportation sector consists of the aviation business both in the passenger and cargo segments, its maritime business providing feeder operations and agency services for international shipping partners, its outbound travel agency services via Hemas Travels and its logistics business unit consists of integrated logistic services.
Company Coordinates stock-summary
Company Details
No 75, Braybrooke Place, Colombo 02 , COLOMBO None : 01
stock-summary
Tel: 94 11 4731713
stock-summary
Registrar Details